2021 Form 10-K Financial Statement

#000121390022016151 Filed on March 30, 2022

View on sec.gov

Income Statement

Concept 2021 2020
Revenue $9.642M $10.87M
YoY Change -11.27% -0.53%
Cost Of Revenue $9.293M $8.914M
YoY Change 4.25% -5.59%
Gross Profit $349.3K $1.953M
YoY Change -82.12% 31.76%
Gross Profit Margin 3.62% 17.97%
Selling, General & Admin $2.853M $4.153M
YoY Change -31.31% -10.59%
% of Gross Profit 816.76% 212.67%
Research & Development $319.0K $378.0K
YoY Change -15.61% 64.59%
% of Gross Profit 91.32% 19.35%
Depreciation & Amortization $3.088M $2.679M
YoY Change 15.24% -8.51%
% of Gross Profit 884.08% 137.2%
Operating Expenses $3.210M $4.531M
YoY Change -29.16% -7.05%
Operating Profit -$2.861M -$2.578M
YoY Change 10.95% -24.01%
Interest Expense -$539.0K -$288.5K
YoY Change 86.83% -1.94%
% of Operating Profit
Other Income/Expense, Net -$539.0K
YoY Change
Pretax Income -$3.399M -$2.867M
YoY Change 18.58% -86.15%
Income Tax
% Of Pretax Income
Net Earnings -$3.399M -$2.867M
YoY Change 18.58% -86.15%
Net Earnings / Revenue -35.26% -26.38%
Basic Earnings Per Share -$0.74
Diluted Earnings Per Share -$73.69K -$65.72K
COMMON SHARES
Basic Shares Outstanding 4.613M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.859M $957.7K
YoY Change 407.39% -10.91%
Cash & Equivalents $4.859M $957.7K
Short-Term Investments
Other Short-Term Assets $58.79K $73.67K
YoY Change -20.2% -60.61%
Inventory $3.340M $3.705M
Prepaid Expenses
Receivables $714.5K $501.9K
Other Receivables $121.4K $83.63K
Total Short-Term Assets $9.093M $5.322M
YoY Change 70.87% -4.61%
LONG-TERM ASSETS
Property, Plant & Equipment $13.41M $15.61M
YoY Change -14.12% -5.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $13.56M $15.80M
YoY Change -14.18% -5.16%
TOTAL ASSETS
Total Short-Term Assets $9.093M $5.322M
Total Long-Term Assets $13.56M $15.80M
Total Assets $22.65M $21.12M
YoY Change 7.25% -5.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $926.8K $1.235M
YoY Change -24.93% -9.64%
Accrued Expenses $383.7K $229.4K
YoY Change 67.25% -18.41%
Deferred Revenue
YoY Change
Short-Term Debt $4.329M $2.038M
YoY Change 112.37% 1754.56%
Long-Term Debt Due $0.00 $2.299M
YoY Change -100.0% 6.92%
Total Short-Term Liabilities $10.51M $11.40M
YoY Change -7.81% 13.52%
LONG-TERM LIABILITIES
Long-Term Debt $5.250M $904.2K
YoY Change 480.6% -57.95%
Other Long-Term Liabilities $44.18K $0.00
YoY Change -100.0%
Total Long-Term Liabilities $5.294M $904.2K
YoY Change 485.49% -58.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.51M $11.40M
Total Long-Term Liabilities $5.294M $904.2K
Total Liabilities $16.63M $13.11M
YoY Change 26.83% 0.89%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.018M $8.005M
YoY Change
Total Liabilities & Shareholders Equity $22.65M $21.12M
YoY Change 7.25% -5.02%

Cashflow Statement

Concept 2021 2020
OPERATING ACTIVITIES
Net Income -$3.399M -$2.867M
YoY Change 18.58% -86.15%
Depreciation, Depletion And Amortization $3.088M $2.679M
YoY Change 15.24% -8.51%
Cash From Operating Activities -$249.8K -$42.26K
YoY Change 491.2% -106.95%
INVESTING ACTIVITIES
Capital Expenditures -$438.1K -$867.3K
YoY Change -49.49% 537.73%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$438.1K -$867.3K
YoY Change -49.49% 537.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.598M 624.2K
YoY Change 636.6% -136.11%
NET CHANGE
Cash From Operating Activities -249.8K -42.26K
Cash From Investing Activities -438.1K -867.3K
Cash From Financing Activities 4.598M 624.2K
Net Change In Cash 3.910M -285.4K
YoY Change -1470.0% -77.29%
FREE CASH FLOW
Cash From Operating Activities -$249.8K -$42.26K
Capital Expenditures -$438.1K -$867.3K
Free Cash Flow $188.2K $825.1K
YoY Change -77.19% 10.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001106644
CY2021Q4 us-gaap Long Term Construction Loan Current
LongTermConstructionLoanCurrent
USD
CY2020 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
USD
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
USD
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
USD
CY2020 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
USD
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
USD
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD

Files In Submission

Name View Source Status
0001213900-22-016151-index-headers.html Edgar Link pending
0001213900-22-016151-index.html Edgar Link pending
0001213900-22-016151.txt Edgar Link pending
0001213900-22-016151-xbrl.zip Edgar Link pending
cphi-20211231.xsd Edgar Link pending
cphi-20211231_cal.xml Edgar Link unprocessable
cphi-20211231_def.xml Edgar Link unprocessable
cphi-20211231_lab.xml Edgar Link unprocessable
cphi-20211231_pre.xml Edgar Link unprocessable
f10k2021ex10-11_chinapharma.htm Edgar Link pending
f10k2021ex23-1_chinapharma.htm Edgar Link pending
f10k2021ex31-1_chinapharma.htm Edgar Link pending
f10k2021ex31-2_chinapharma.htm Edgar Link pending
f10k2021ex32-1_chinapharma.htm Edgar Link pending
f10k2021ex4-2_chinapharma.htm Edgar Link pending
f10k2021_chinapharma.htm Edgar Link pending
f10k2021_chinapharma_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending